|
Medications taken
|
Percentage (N)
|
SMS
|
SMS
|
|---|
| |
SMS sent (n = 117)
|
SMS not sent (n = 123)
|
SMS risk ratio (95% CI)
|
Risk difference (95% CI)
|
|---|
|
1 Took anti-malarial
|
23.1% (27)
|
41.5% (51)
|
0.42 (0.25–0.72)
|
−18.4% (−30.1% to −6.7%)
|
|
2 Took anti-malarial**
| | |
0.37 (0.20–0.69)
|
−20.6% (−32.5% to −8.8%)
|
|
3 Took symptom drug
|
73.5% (86)
|
80.5% (99)
|
0.67 (0.37–1.20)
|
−7.0% (−17.3% to 3.31%)
|
|
4 Took symptom drug**
| | |
0.89 (0.42–1.90)
|
−2.1% (−15.2% to 11.1%)
|
- Sample includes RDT negative participants who bought both an antimalarial drug as well as drugs to treat their symptoms, N = 240.
- **Controls for city survey was conducted (Ibadan/Ogbomosho), treatment* city survey was conducted, whether assignment to the treatment/control group was made off-protocol, and treatment* whether survey assignment to the treatment/control group was made off-protocol (Model 3).
- Standard errors are clustered by retail site.
